Skip to main content

Table 3 Mean values of nerve conduction study of studied groups and post hoc analysis

From: Evaluation of peripheral and autonomic nervous systems dysfunctions in patients with Parkinson’s disease

 

Controls

Drug-naïve patients with PD

Patients with PD on dopaminergic drugs

F-value

p-value

Tukey test

Median motor

Latency (ms)

3.87 ± 0.27

3.78 ± 0.24

3.75 ± 0.32

0.666

0.575

P1:0.579

P2:0.585

P3:0.572

Amplitude (mv)

5.45 ± 0.61

5.94 ± 0.52

5 ± 0.85

2.26

0.097

P1:0.093

P2:0.081

P3:0.091

Conduction Velocity (m/s)

59.25 ± 4.67

58.15 ± 4.97

58.92 ± 4.79

0.173

0.192

P1:0.180

P2:0.195

P3:0.193

F-wave latency (ms)

27.17 ± 0.92

27.15 ± 0.87

27.39 ± 1.34

1.01

0.39

P1:0.38

P2:0.41

P3:0.37

Median sensory

Latency (ms)

2.2 ± 0.16

2.81 ± 0.11

3.4 ± 0.32

64.2

0.001

P1:0.001

P2:0.001

P3:0.001

Amplitude (µv)

26.5 ± 3

22.55 ± 4.5

18.21 ± 8.14

4.55

0.008

P1:0.007

P2:0.001

P3: 0.009

Conduction velocity (m/s)

56.1 ± 3.51

52.65 ± 6.16

49.29 ± 3.03

26.57

0.01

P1:0.02

P2:0.001

P3:0.03

Ulnar motor

Latency (ms)

2.98 ± 0.26

2.98 ± 0.20

3.05 ± 0.32

0.349

0.789

P1:0.768

p2:0.672

P3:0.732

Amplitude (mv)

8.35 ± 0.79

8.44 ± 0.71

7.83 ± 1.32

1.58

0.199

P1:0.232

P2:0.192

P3:0.187

Conduction velocity (m/s)

53.5 ± 3.25

53.55 ± 3.10

54.42 ± 4.22

2.33

0.08

P1:0.082

P2:0.067

P3:0.079

F-wave latency (ms)

29.19 ± 1.14

29.08 ± 0.73

29.87 ± 0.84

1.84

0.155

P1:0.192

P2:0.137

P3:0.142

Ulnar sensory

Latency (ms)

2.38 ± 0.130

2.44 ± 0.16

2.95 ± 0.21

25.44

0.025

P1: 0.042

P2: 0.012

P3:0.032

Amplitude (µv)

20.2 ± 1.67

18 ± 2.79

15.42 ± 4.99

7.42

0.015

P1: 0.01

P2: 0.01

P3:0.01

Conduction velocity (m/s)

62.35 ± 5.04

58.8 ± 5.81

48.59 ± 5.42

14.09

0.008

P1:0.009

P2: 0.001

P3:0.001

Radial sensory

Latency (ms)

2.22 ± 0.13

2.41 ± 0.16

2.78 ± 0.21

23.22

0.033

P1: 0.041

P2: 0.032

P3:0.029

Amplitude (µv)

17.10 ± 1.07

15.55 ± 2.94

13.50 ± 4.54

5.89

0.012

P1: 0.013

P2:0.008

P3:0.015

Conduction velocity (m/s)

69.4 ± 4.16

56.75 ± 6.54

49.79 ± 4.42

26.44

0.001

P1:0.001

P2:0.001

P3:0.001

Tibial nerve

Latency (ms)

5.16 ± 0.23

5.03 ± 0.14

5.15 ± 0.58

1.262

0.293

P1: 0.341

P2: 0.272

P3:0.313

Amplitude (mv)

5.5 ± 0.24

5.62 ± 0.21

5.3 ± 0.89

0.739

0.535

P1:0.512

P2: 0.522

P3:0.519

Conduction velocity (m/s)

56.85 ± 7.90

55.55 ± 5.95

57.73 ± 8.20

0.39

0.759

P1:0.723

P2:0.562

P3:0.234

F-wave latency (ms)

47.25 ± 1.94

46.93 ± 1.13

47.37 ± 3.22

1.785

0.156

P1: 0.097

P2: 0.088

P3:0.123

Peroneal nerve

Latency (ms)

4.86 ± 0.28

5.04 ± 0.3

6.06 ± 0.79

18.82

0.024

P1:0.059

P2:0.027

P3:0.018

Amplitude (mv)

3.48 ± 0.42

3.92 ± 0.44

2.87 ± 0.65

14.67

0.001

P1: 0.001

P2: 0.001

P3:0.001

Conduction velocity (m/s)

67.25 ± 8.92

65.47 ± 8.73

52.4 ± 8.62

7.85

0.001

P1: 0.001

P2: 0.001

P3:0.001

F-wave latency (ms)

46.25 ± 1.06

45.85 ± 1.07

46.23 ± 1.35

1.35

0.27

P1:0.137

P2: 0.279

P3:0.152

Sural nerve

latency (ms)

2.92 ± 0.13

3.22 ± 0.14

3.71 ± 0.24

40.71

0.001

P1: 0.001

P2: 0.001

P3:0.001

Amplitude (µv)

16.5 ± 1.9

12.33 ± 7.06

5.31 ± 1.57

9.28

0.001

P1: 0.001

P2:0.001

P3:0.001

Conduction velocity (m/s)

62.33 ± 4.08

57.8 ± 3.79

49.13 ± 2.53

28.72

0.001

P1:0.001

P2: 0.001

P3:0.001

  1. (ms) millisecond; (mv) microvolt; (m/s) meter per second; (µv) microvot; P1 (control versus drug-naïve patients with PD). P2 (control versus patients on dopaminergic drugs). P3 (drug-naïve patients with PD versus patients on dopaminergic drugs)